Skip to main content

RABEPRAZOLE SODIUM

NDC 50090-6887 · A-S Medication Solutions

Generic namerabeprazole sodium
Dosage formTABLET, DELAYED RELEASE
RouteORAL
Active ingredient(s)RABEPRAZOLE SODIUM
Strength20 mg/1
Pharmacologic classProton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
Marketing categoryANDA

Packages

50090-6887-0 — 30 TABLET, DELAYED RELEASE in 1 BOTTLE (50090-6887-0)

50090-6887-1 — 90 TABLET, DELAYED RELEASE in 1 BOTTLE (50090-6887-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

13668-107 — Rabeprazole sodium, 50090-4751 — Rabeprazole Sodium, 51407-184 — Rabeprazole Sodium, 60760-560 — Rabeprazole Sodium, 60760-972 — rabeprazole sodium, 62135-503 — Rabeprazole Sodium, 62175-302 — Rabeprazole Sodium, 63187-259 — Rabeprazole Sodium, 63187-555 — Rabeprazole sodium, 65162-724 — Rabeprazole, 65862-721 — Rabeprazole Sodium, 67877-443 — Rabeprazole Sodium, 68788-4060 — Rabeprazole sodium, 68788-7459 — Rabeprazole Sodium, 68788-8536 — rabeprazole sodium, 70518-2590 — Rabeprazole Sodium, 70518-3209 — rabeprazole sodium, 71205-292 — Rabeprazole Sodium, 71205-603 — rabeprazole sodium, 71335-0244 — Rabeprazole Sodium, +17 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels